Chainalysis has bought Excygent, a cybercrime investigation company
Together, they will study the use of cryptocurrencies in hacker attacks
07.10.2021 - 08:10
970
1 min
0
What's new? Chainalysis, an analytical blockchain company, has acquired Excygent, a cybercrime investigation company, according to its press release. The amount of the transaction is not disclosed.
Why did Chainalysis buy Excygent? Chainalysis CEO Michael Gronager stated that Excygent’ employees will join the Chainalysis team to investigate the use of cryptocurrencies in cybercrimes. Previously, the parties had already cooperated in the course of studying the anonymous online darknet market Silk Road.
What else is known about Chainalysis? In 2020, the company participated in a cybercrime investigation of the NetWalker ransomware that had attacked software in US hospitals. At that time the hospitals paid $25 million in ransom.
The project has grown significantly over the past year, receiving support from both the US government and the private sector. In June, the company reached a valuation of $4,2 billion after another $100 million round of funding. It was led by the global investment company Coatue.
Useful material?
Technologies
Network fees will be integrated into the cost of swaps
Nov 22, 2024
Market
The company’s unrealized profits from investing in its first cryptocurrency approached $14 billion
Nov 19, 2024
Incidents
The search, the reason for which was not announced, took place a week after the election, the results of which Polymarket users predicted quite accurately
Nov 14, 2024
Market
Analysts point to the growing popularity of the first cryptocurrency as a safe haven asset
Nov 13, 2024
Market
The product will begin trading on the Swiss Exchange on November 19
Nov 12, 2024
Market
The company’s unrealized profits from investing in the first cryptocurrency approached $13 billion
Nov 12, 2024